GAPDH and Hyperglycemia: Hyperglycaemia increases the availability of the glycolytic intermediate glyceraldehyde-3-phosphate (GAP), a DAG precursor, due to the inhibition of the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by the PARylation process [85].